Hello, Fool! | Login | Signup | My Fool
Oct 7, 2008 7:39 PM ET | Feedback | Site Changes | Help
A biopharmaceutical company which advances oncology care by developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers.
View All Commentary (IMCL)
Recs
Cavern1 (< 20) Submitted: 12/11/06 3:03 PM : Start Price: $29.36 IMCL Score: 157.54
With Carl onboard you know he will either sell the company or grow the company, either way it's a win for long investors
Report this Post Replies: 0 | Reply
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK